{"abstract": "The Irish drug maker Shire is paying a premium for NPS Pharmaceuticals, which is based in New Jersey, as part of its effort to recover from its botched sale to AbbVie last year.", "web_url": "https://dealbook.nytimes.com/2015/01/11/shire-to-buy-nps-pharmaceuticals-for-5-2-billion/", "snippet": "The Irish drug maker Shire is paying a premium for NPS Pharmaceuticals, which is based in New Jersey, as part of its effort to recover from its botched sale to AbbVie last year.", "lead_paragraph": "The Irish drug maker Shire has agreed to acquire NPS Pharmaceuticals for $5.2 billion, a deal that will allow it to move on from its botched sale to AbbVie last year.", "print_section": "B", "print_page": "2", "source": "The New York Times", "multimedia": [{"rank": 0, "subtype": "xlarge", "caption": null, "credit": null, "type": "image", "url": "images/2015/01/12/business/12skymain1/12skymain1-articleLarge.jpg", "height": 394, "width": 600, "subType": "xlarge", "crop_name": "articleLarge", "legacy": {"xlarge": "images/2015/01/12/business/12skymain1/12skymain1-articleLarge.jpg", "xlargewidth": 600, "xlargeheight": 394}}, {"rank": 0, "subtype": "jumbo", "caption": null, "credit": null, "type": "image", "url": "images/2015/01/12/business/12skymain1/12skymain1-jumbo.jpg", "height": 673, "width": 1024, "subType": "jumbo", "crop_name": "jumbo", "legacy": {}}, {"rank": 0, "subtype": "superJumbo", "caption": null, "credit": null, "type": "image", "url": "images/2015/01/12/business/12skymain1/12skymain1-superJumbo.jpg", "height": 1346, "width": 2048, "subType": "superJumbo", "crop_name": "superJumbo", "legacy": {}}, {"rank": 0, "subtype": "thumbnail", "caption": null, "credit": null, "type": "image", "url": "images/2015/01/12/business/12skymain1/12skymain1-thumbStandard.jpg", "height": 75, "width": 75, "subType": "thumbnail", "crop_name": "thumbStandard", "legacy": {"thumbnail": "images/2015/01/12/business/12skymain1/12skymain1-thumbStandard.jpg", "thumbnailwidth": 75, "thumbnailheight": 75}}, {"rank": 0, "subtype": "thumbLarge", "caption": null, "credit": null, "type": "image", "url": "images/2015/01/12/business/12skymain1/12skymain1-thumbLarge.jpg", "height": 150, "width": 150, "subType": "thumbLarge", "crop_name": "thumbLarge", "legacy": {}}], "headline": {"main": "Shire to Buy NPS Pharmaceuticals for $5.2 Billion", "kicker": "DealBook", "content_kicker": null, "print_headline": "Shire to Buy NPS Pharmaceuticals for $5.2 Billion", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": 1, "major": "N"}, {"name": "organizations", "value": "AbbVie Inc", "rank": 2, "major": "N"}, {"name": "organizations", "value": "NPS Pharmaceuticals Inc", "rank": 3, "major": "N"}, {"name": "organizations", "value": "Shire PLC", "rank": 4, "major": "N"}], "pub_date": "2015-01-11T18:27:48+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By David Gelles", "person": [{"firstname": "David", "middlename": null, "lastname": "Gelles", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/584dd7a1-d55b-5852-a7b2-a5a30faddb52", "word_count": 787, "uri": "nyt://article/584dd7a1-d55b-5852-a7b2-a5a30faddb52"}